The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Drug Eluting Stents (DES)-Global Market Insights and Sales Trends 2025
Synopsis
The global Drug Eluting Stents (DES) market size is expected to reach US$ 2425.9 million by 2029, growing at a CAGR of 7.6% from 2023 to 2029. The market is mainly driven by the significant applications of Drug Eluting Stents (DES) in various end use industries. The expanding demands from the Coronary Heart Disease and Clinical, are propelling Drug Eluting Stents (DES) market. Cobalt-chromium Alloy Stents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Magnesium Alloy Stents segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Materials, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drug Eluting Stents (DES), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drug Eluting Stents (DES) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drug Eluting Stents (DES) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drug Eluting Stents (DES) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drug Eluting Stents (DES) covered in this report include Abbott Vascular, Advantec Vascular, B.Braun Melsengen AG, Biosensors, Biotronik, Blue Medical, Boston Scientific, DISA Vascular and Essen, etc.
The global Drug Eluting Stents (DES) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
Global Drug Eluting Stents (DES) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug Eluting Stents (DES) market, Segment by Materials:
Cobalt-chromium Alloy Stents
Magnesium Alloy Stents
Tyrosine Polycarbonate Stents
Nitinol Stents
Platinum Chromium Alloy Stents
Stainless Steel Stents
Other Materials
Global Drug Eluting Stents (DES) market, by Application
Coronary Heart Disease
Clinical
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Materials, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Drug Eluting Stents (DES) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Drug Eluting Stents (DES) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Drug Eluting Stents (DES) market size is expected to reach US$ 2425.9 million by 2029, growing at a CAGR of 7.6% from 2023 to 2029. The market is mainly driven by the significant applications of Drug Eluting Stents (DES) in various end use industries. The expanding demands from the Coronary Heart Disease and Clinical, are propelling Drug Eluting Stents (DES) market. Cobalt-chromium Alloy Stents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Magnesium Alloy Stents segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Materials, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drug Eluting Stents (DES), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drug Eluting Stents (DES) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drug Eluting Stents (DES) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drug Eluting Stents (DES) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drug Eluting Stents (DES) covered in this report include Abbott Vascular, Advantec Vascular, B.Braun Melsengen AG, Biosensors, Biotronik, Blue Medical, Boston Scientific, DISA Vascular and Essen, etc.
The global Drug Eluting Stents (DES) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
Global Drug Eluting Stents (DES) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug Eluting Stents (DES) market, Segment by Materials:
Cobalt-chromium Alloy Stents
Magnesium Alloy Stents
Tyrosine Polycarbonate Stents
Nitinol Stents
Platinum Chromium Alloy Stents
Stainless Steel Stents
Other Materials
Global Drug Eluting Stents (DES) market, by Application
Coronary Heart Disease
Clinical
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Materials, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Drug Eluting Stents (DES) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Drug Eluting Stents (DES) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Drug Eluting Stents (DES) Market Overview
1.1 Drug Eluting Stents (DES) Product Overview
1.2 Drug Eluting Stents (DES) Market Segment by Materials
1.2.1 Cobalt-chromium Alloy Stents
1.2.2 Magnesium Alloy Stents
1.2.3 Tyrosine Polycarbonate Stents
1.2.4 Nitinol Stents
1.2.5 Platinum Chromium Alloy Stents
1.2.6 Stainless Steel Stents
1.2.7 Other Materials
1.3 Global Drug Eluting Stents (DES) Market Size by Materials
1.3.1 Global Drug Eluting Stents (DES) Market Size Overview by Materials (2018-2029)
1.3.2 Global Drug Eluting Stents (DES) Historic Market Size Review by Materials (2018-2023)
1.3.3 Global Drug Eluting Stents (DES) Forecasted Market Size by Materials (2024-2029)
1.4 Key Regions Market Size Segment by Materials
1.4.1 North America Drug Eluting Stents (DES) Sales Breakdown by Materials (2018-2023)
1.4.2 Europe Drug Eluting Stents (DES) Sales Breakdown by Materials (2018-2023)
1.4.3 Asia-Pacific Drug Eluting Stents (DES) Sales Breakdown by Materials (2018-2023)
1.4.4 Latin America Drug Eluting Stents (DES) Sales Breakdown by Materials (2018-2023)
1.4.5 Middle East and Africa Drug Eluting Stents (DES) Sales Breakdown by Materials (2018-2023)
2 Global Drug Eluting Stents (DES) Market Competition by Company
2.1 Global Top Players by Drug Eluting Stents (DES) Sales (2018-2023)
2.2 Global Top Players by Drug Eluting Stents (DES) Revenue (2018-2023)
2.3 Global Top Players by Drug Eluting Stents (DES) Price (2018-2023)
2.4 Global Top Manufacturers Drug Eluting Stents (DES) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Drug Eluting Stents (DES) Market Competitive Situation and Trends
2.5.1 Drug Eluting Stents (DES) Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Drug Eluting Stents (DES) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Eluting Stents (DES) as of 2022)
2.7 Date of Key Manufacturers Enter into Drug Eluting Stents (DES) Market
2.8 Key Manufacturers Drug Eluting Stents (DES) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Drug Eluting Stents (DES) Status and Outlook by Region
3.1 Global Drug Eluting Stents (DES) Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Drug Eluting Stents (DES) Historic Market Size by Region
3.2.1 Global Drug Eluting Stents (DES) Sales in Volume by Region (2018-2023)
3.2.2 Global Drug Eluting Stents (DES) Sales in Value by Region (2018-2023)
3.2.3 Global Drug Eluting Stents (DES) Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Drug Eluting Stents (DES) Forecasted Market Size by Region
3.3.1 Global Drug Eluting Stents (DES) Sales in Volume by Region (2024-2029)
3.3.2 Global Drug Eluting Stents (DES) Sales in Value by Region (2024-2029)
3.3.3 Global Drug Eluting Stents (DES) Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Drug Eluting Stents (DES) by Application
4.1 Drug Eluting Stents (DES) Market Segment by Application
4.1.1 Coronary Heart Disease
4.1.2 Clinical
4.2 Global Drug Eluting Stents (DES) Market Size by Application
4.2.1 Global Drug Eluting Stents (DES) Market Size Overview by Application (2018-2029)
4.2.2 Global Drug Eluting Stents (DES) Historic Market Size Review by Application (2018-2023)
4.2.3 Global Drug Eluting Stents (DES) Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Drug Eluting Stents (DES) Sales Breakdown by Application (2018-2023)
4.3.2 Europe Drug Eluting Stents (DES) Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Drug Eluting Stents (DES) Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Drug Eluting Stents (DES) Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Drug Eluting Stents (DES) Sales Breakdown by Application (2018-2023)
5 North America Drug Eluting Stents (DES) by Country
5.1 North America Drug Eluting Stents (DES) Historic Market Size by Country
5.1.1 North America Drug Eluting Stents (DES) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Drug Eluting Stents (DES) Sales in Volume by Country (2018-2023)
5.1.3 North America Drug Eluting Stents (DES) Sales in Value by Country (2018-2023)
5.2 North America Drug Eluting Stents (DES) Forecasted Market Size by Country
5.2.1 North America Drug Eluting Stents (DES) Sales in Volume by Country (2024-2029)
5.2.2 North America Drug Eluting Stents (DES) Sales in Value by Country (2024-2029)
6 Europe Drug Eluting Stents (DES) by Country
6.1 Europe Drug Eluting Stents (DES) Historic Market Size by Country
6.1.1 Europe Drug Eluting Stents (DES) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Drug Eluting Stents (DES) Sales in Volume by Country (2018-2023)
6.1.3 Europe Drug Eluting Stents (DES) Sales in Value by Country (2018-2023)
6.2 Europe Drug Eluting Stents (DES) Forecasted Market Size by Country
6.2.1 Europe Drug Eluting Stents (DES) Sales in Volume by Country (2024-2029)
6.2.2 Europe Drug Eluting Stents (DES) Sales in Value by Country (2024-2029)
7 Asia-Pacific Drug Eluting Stents (DES) by Region
7.1 Asia-Pacific Drug Eluting Stents (DES) Historic Market Size by Region
7.1.1 Asia-Pacific Drug Eluting Stents (DES) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Drug Eluting Stents (DES) Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Drug Eluting Stents (DES) Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Drug Eluting Stents (DES) Forecasted Market Size by Region
7.2.1 Asia-Pacific Drug Eluting Stents (DES) Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Drug Eluting Stents (DES) Sales in Value by Region (2024-2029)
8 Latin America Drug Eluting Stents (DES) by Country
8.1 Latin America Drug Eluting Stents (DES) Historic Market Size by Country
8.1.1 Latin America Drug Eluting Stents (DES) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Drug Eluting Stents (DES) Sales in Volume by Country (2018-2023)
8.1.3 Latin America Drug Eluting Stents (DES) Sales in Value by Country (2018-2023)
8.2 Latin America Drug Eluting Stents (DES) Forecasted Market Size by Country
8.2.1 Latin America Drug Eluting Stents (DES) Sales in Volume by Country (2024-2029)
8.2.2 Latin America Drug Eluting Stents (DES) Sales in Value by Country (2024-2029)
9 Middle East and Africa Drug Eluting Stents (DES) by Country
9.1 Middle East and Africa Drug Eluting Stents (DES) Historic Market Size by Country
9.1.1 Middle East and Africa Drug Eluting Stents (DES) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Drug Eluting Stents (DES) Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Drug Eluting Stents (DES) Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Drug Eluting Stents (DES) Forecasted Market Size by Country
9.2.1 Middle East and Africa Drug Eluting Stents (DES) Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Drug Eluting Stents (DES) Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Abbott Vascular
10.1.1 Abbott Vascular Company Information
10.1.2 Abbott Vascular Introduction and Business Overview
10.1.3 Abbott Vascular Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Abbott Vascular Drug Eluting Stents (DES) Products Offered
10.1.5 Abbott Vascular Recent Development
10.2 Advantec Vascular
10.2.1 Advantec Vascular Company Information
10.2.2 Advantec Vascular Introduction and Business Overview
10.2.3 Advantec Vascular Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Advantec Vascular Drug Eluting Stents (DES) Products Offered
10.2.5 Advantec Vascular Recent Development
10.3 B.Braun Melsengen AG
10.3.1 B.Braun Melsengen AG Company Information
10.3.2 B.Braun Melsengen AG Introduction and Business Overview
10.3.3 B.Braun Melsengen AG Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2018-2023)
10.3.4 B.Braun Melsengen AG Drug Eluting Stents (DES) Products Offered
10.3.5 B.Braun Melsengen AG Recent Development
10.4 Biosensors
10.4.1 Biosensors Company Information
10.4.2 Biosensors Introduction and Business Overview
10.4.3 Biosensors Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Biosensors Drug Eluting Stents (DES) Products Offered
10.4.5 Biosensors Recent Development
10.5 Biotronik
10.5.1 Biotronik Company Information
10.5.2 Biotronik Introduction and Business Overview
10.5.3 Biotronik Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Biotronik Drug Eluting Stents (DES) Products Offered
10.5.5 Biotronik Recent Development
10.6 Blue Medical
10.6.1 Blue Medical Company Information
10.6.2 Blue Medical Introduction and Business Overview
10.6.3 Blue Medical Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Blue Medical Drug Eluting Stents (DES) Products Offered
10.6.5 Blue Medical Recent Development
10.7 Boston Scientific
10.7.1 Boston Scientific Company Information
10.7.2 Boston Scientific Introduction and Business Overview
10.7.3 Boston Scientific Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Boston Scientific Drug Eluting Stents (DES) Products Offered
10.7.5 Boston Scientific Recent Development
10.8 DISA Vascular
10.8.1 DISA Vascular Company Information
10.8.2 DISA Vascular Introduction and Business Overview
10.8.3 DISA Vascular Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2018-2023)
10.8.4 DISA Vascular Drug Eluting Stents (DES) Products Offered
10.8.5 DISA Vascular Recent Development
10.9 Essen
10.9.1 Essen Company Information
10.9.2 Essen Introduction and Business Overview
10.9.3 Essen Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Essen Drug Eluting Stents (DES) Products Offered
10.9.5 Essen Recent Development
10.10 Medtronic Vascular
10.10.1 Medtronic Vascular Company Information
10.10.2 Medtronic Vascular Introduction and Business Overview
10.10.3 Medtronic Vascular Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Medtronic Vascular Drug Eluting Stents (DES) Products Offered
10.10.5 Medtronic Vascular Recent Development
10.11 MicroPort Medical
10.11.1 MicroPort Medical Company Information
10.11.2 MicroPort Medical Introduction and Business Overview
10.11.3 MicroPort Medical Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2018-2023)
10.11.4 MicroPort Medical Drug Eluting Stents (DES) Products Offered
10.11.5 MicroPort Medical Recent Development
10.12 MIV Therapeutics
10.12.1 MIV Therapeutics Company Information
10.12.2 MIV Therapeutics Introduction and Business Overview
10.12.3 MIV Therapeutics Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2018-2023)
10.12.4 MIV Therapeutics Drug Eluting Stents (DES) Products Offered
10.12.5 MIV Therapeutics Recent Development
10.13 Orbusneich
10.13.1 Orbusneich Company Information
10.13.2 Orbusneich Introduction and Business Overview
10.13.3 Orbusneich Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Orbusneich Drug Eluting Stents (DES) Products Offered
10.13.5 Orbusneich Recent Development
10.14 Promed Medical
10.14.1 Promed Medical Company Information
10.14.2 Promed Medical Introduction and Business Overview
10.14.3 Promed Medical Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Promed Medical Drug Eluting Stents (DES) Products Offered
10.14.5 Promed Medical Recent Development
10.15 Relisys Medical
10.15.1 Relisys Medical Company Information
10.15.2 Relisys Medical Introduction and Business Overview
10.15.3 Relisys Medical Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Relisys Medical Drug Eluting Stents (DES) Products Offered
10.15.5 Relisys Medical Recent Development
10.16 Reva Medical
10.16.1 Reva Medical Company Information
10.16.2 Reva Medical Introduction and Business Overview
10.16.3 Reva Medical Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Reva Medical Drug Eluting Stents (DES) Products Offered
10.16.5 Reva Medical Recent Development
10.17 Sahajanand
10.17.1 Sahajanand Company Information
10.17.2 Sahajanand Introduction and Business Overview
10.17.3 Sahajanand Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Sahajanand Drug Eluting Stents (DES) Products Offered
10.17.5 Sahajanand Recent Development
10.18 Sino Medical
10.18.1 Sino Medical Company Information
10.18.2 Sino Medical Introduction and Business Overview
10.18.3 Sino Medical Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Sino Medical Drug Eluting Stents (DES) Products Offered
10.18.5 Sino Medical Recent Development
10.19 Sorin
10.19.1 Sorin Company Information
10.19.2 Sorin Introduction and Business Overview
10.19.3 Sorin Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Sorin Drug Eluting Stents (DES) Products Offered
10.19.5 Sorin Recent Development
10.20 Terumo Medical
10.20.1 Terumo Medical Company Information
10.20.2 Terumo Medical Introduction and Business Overview
10.20.3 Terumo Medical Drug Eluting Stents (DES) Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Terumo Medical Drug Eluting Stents (DES) Products Offered
10.20.5 Terumo Medical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Drug Eluting Stents (DES) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Drug Eluting Stents (DES) Industrial Chain Analysis
11.4 Drug Eluting Stents (DES) Market Dynamics
11.4.1 Drug Eluting Stents (DES) Industry Trends
11.4.2 Drug Eluting Stents (DES) Market Drivers
11.4.3 Drug Eluting Stents (DES) Market Challenges
11.4.4 Drug Eluting Stents (DES) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Drug Eluting Stents (DES) Distributors
12.3 Drug Eluting Stents (DES) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
